Vascular Graft Market

The Global Vascular Graft Market is valued at US$ 1.79 Billion in 2022 and is expected to reach US$ 2.95 Billion by 2029 with a CAGR of 7.38% over the forecast period.  

Global Vascular Graft Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2023-2029- Increasing prevalence of cardiovascular diseases and technological advancements in this field are driving the growth of the Global Vascular Graft Market.

Scope of Global Vascular Graft Market Report-

A vascular graft is a medical device used to replace or bypass damaged or diseased blood vessels in the body. It is designed to restore blood flow to organs or tissues by creating a new pathway for blood circulation. Vascular grafts are typically made from synthetic materials or harvested from the patient's own veins or arteries and can be used in various surgical procedures, such as coronary artery bypass grafting (CABG) or peripheral vascular bypass surgeries.

Vascular grafts can be used in a variety of procedures, including coronary artery bypass surgery, peripheral vascular surgery, and dialysis access surgery. The type of graft used depends on the location and extent of the vascular problem, as well as the patient's overall health.

Synthetic grafts are made of materials such as expanded polytetrafluoroethylene (ePTFE) or Dacron polyester, while biological grafts can be made from human tissue (such as veins) or animal tissue (such as bovine pericardium). In the 1950s, the first synthetic vascular grafts were developed using materials such as Dacron and Teflon.

The Covid-19 pandemic has had a negative impact on the growth of the global vascular graft market. Like many other medical procedures, vascular surgeries have been affected by the pandemic due to delays in non-emergency surgeries, reduced hospital capacity, and the need to conserve resources for Covid-19 patients. This has resulted in a decline in the number of vascular surgeries performed, which has affected the demand for vascular grafts.

Global vascular graft market is segmented based on working product, graft material, application, end-user and region & country level. Based on Product, the vascular graft market is segmented into coronary artery bypass grafts, peripheral vascular grafts, endovascular stent grafts, haemodialysis access grafts. Based on Graft Material, the vascular graft market is segmented into polytetrafluoroethylene, polyethylene terephthalate, polyamide, polyurethanes. Based on application, the vascular graft market is segmented into kidney failure, cardiac aneurysm, vascular occlusion and coronary artery disease. Based on end user the vascular graft market is segmented into hospitals, ambulatory surgical centres, cardiac catheterization labs.

The regions covered in this vascular graft market are North America, Europe, Asia-Pacific, Latin, and the Middle East. Based on a country level, the market of vascular graft is subdivided into the U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, Southeast Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc. 

Key Players for Global Vascular Graft Market Report– 

Some of the key players in global vascular graft market report are -

• Abbott Laboratories
• Braun Melsungen AG
• R. Bard Inc.
• Cardinal Health Inc.
• Cook Medical
• CryoLife Inc.
• Endologix Inc.
• Japan Lifeline Co. Ltd.
• LeMaitre Vascular Inc.
• MAQUET Holding B.V. & Co. KG (Getinge AB)
• Medtronic plc
• Novatech SA
• Terumo Corporation
• Vascular Grafts Solutions Ltd.
• L. Gore & Associates Inc.
• Others

Global Vascular Graft Market Segmentation:– 

By Product:

• Coronary Artery Bypass Grafts
• Peripheral Vascular Grafts
• Endovascular Stent Grafts
• Hemodialysis Access Grafts

By Graft Material: 

• Polytetrafluoroethylene (Teflon)
• Polyethylene Terephthalate (Dacron)
• Polyamide (Nylon)
• Polyurethanes

By Application: 

• Kidney Failure
• Cardiac Aneurysm
• Vascular Occlusion
• Coronary Artery Disease

By End user: 

• Hospitals
• Ambulatory Surgical centers
• Cardiac Catheterization Labs

By Regional & Country Analysis:

• North America

• U.S.
• Mexico
• Canada

• Europe

• UK
• France
• Germany
• Italy

• The Asia Pacific

• China
• Japan
• India
• Southeast Asia

• South America

• Brazil,
• Argentina
• Columbia

• The Middle East and Africa

• GCC
• Africa
• Rest of the Middle East and Africa

Global Vascular Graft Market Dynamics– 

The increasing prevalence of cardiovascular diseases is one of the key factors driving the demand for vascular grafts market. Cardiovascular diseases, including coronary artery disease, peripheral artery disease, and aneurysms, are among the leading causes of death worldwide.

For instance; according to the World Health Organization (WHO), cardiovascular diseases account for approximately 17.9 million deaths each year, representing 31% of all global deaths. As the population ages and lifestyles become more sedentary, the incidence of these diseases is expected to continue to rise.

Vascular grafts are a critical component of the treatment for many cardiovascular diseases. They are used to bypass obstructed or damaged blood vessels, restore blood flow, and prevent further damage. In many cases, vascular grafts can help patients avoid more invasive surgeries or amputations.

Overall, the increasing prevalence of cardiovascular diseases is likely to continue driving the vascular graft market growth, as healthcare providers seek to provide effective and minimally invasive treatments to their patients.

In addition, the vascular graft market has been driven by various technological advancements that have improved the outcomes of vascular surgeries and expanded the range of conditions that can be treated with these devices. The development of tissue-engineered grafts is one of the examples of technological advancements in vascular grafts. Tissue-engineered grafts promote natural healing and regeneration and reduce the risk of rejection, expanding the range of conditions that can be treated with these devices.

Also, 3D printing technology has been used to create patient-specific vascular grafts that fit the patient's anatomy, reducing the risk of complications and improving the overall outcome of the surgery. For instance; according to study published in the journal of Vascular Surgery in 2021 3D-printed vascular grafts are cost effective compared to traditional synthetic vascular grafts for use in peripheral arterial disease (PAD) patients.

Thus, technological advancements in vascular grafts have contributed to the growth of the vascular graft market by improving outcomes, expanding the range of conditions that can be treated, and increasing demand.

However, high cost of vascular surgeries, stringent regulatory requirements, lack of awareness all these factors are affecting the growth of vascular graft market. Furthermore, increasing geriatric population, availability of skilled surgeons, increasing healthcare expenditure is growing the demand for vascular graft in future.

Global Vascular Graft Market Regional Analysis– 

North America:

Geographically, North America accounts for the leading share in the vascular graft market due to the high prevalence of cardiovascular diseases and the presence of well-established healthcare infrastructure. For instance; according to the American Heart Association, cardiovascular diseases accounted for 836,546 deaths in the United States in 2020. The growing demand for minimally invasive surgeries and the increasing adoption of advanced vascular grafts are expected to drive the market growth in this region.

Furthermore, the presence of major market players, and high healthcare spending, high adoption rate of advanced vascular grafts, and the rising geriatric population are some of the factors driving the growth of the market in the region.

Europe:

Europe is the second dominating region for the vascular graft market. Rising geriatric population and the high prevalence of cardiovascular diseases drive the market for vascular grafts in this region. For example; according to the European Heart Network, cardiovascular diseases account for 3.9 million deaths in Europe each year.

The growing demand for minimally invasive surgeries and the increasing adoption of tissue-engineered grafts and other advanced vascular grafts are expected to drive the market growth in this region. In addition, the presence of key players in the region and their focus on research and development of new and innovative products is expected to drive the growth of the vascular graft market in Europe.

News: -

FDA Approved Expanded Indication for Gore Cardiovascular Stent Graft for Treatment of Aortic Dissection

On March 2^nd, 2022; The Gore Cardiovascular Stent Graft, a device used in the treatment of aortic dissection, had received an expanded indication from the U.S. Food and Drug Administration (FDA). The expanded indication allowed for the use of the device in patients with aortic dissection involving the descending thoracic aorta. Previously, the device was approved for use in patients with abdominal aortic aneurysms and thoracic aortic aneurysms. The Gore Cardiovascular Stent Graft served as a minimally invasive option for treating aortic dissection, which was a serious condition that could lead to life-threatening complications if left untreated. This approval provided another treatment option for patients with aortic dissection and expanded the use of the device in the cardiovascular market.

Researchers Developed New Vascular Graft that Incorporates Smart Nanotechnology

On October 20^th, 2021; Researchers developed a new vascular graft that incorporated smart nanotechnology, as per a news article. The technology used tiny sensors made of nanomaterials that were integrated into the graft to monitor its performance and detect any problems early on. The graft was designed to be more durable and longer lasting than traditional grafts, which often need to be replaced after several years. The smart graft had potential applications in treating a range of conditions, including peripheral artery disease and aneurysms. The researchers had tested the technology in laboratory experiments and were planning to conduct clinical trials in the future to evaluate its safety and effectiveness in human patients. The development of this new technology had the potential to revolutionize the field of vascular surgery and improve outcomes for patients in need of vascular grafts.

Endologix Received FDA Approval for Alto Abdominal Stent Graft System

On March 16^th, 2020;  Endologix, a medical device company specializing in the treatment of aortic disorders, announced that it had received approval from the U.S. FDA for its Alto Abdominal Stent Graft System. The Alto system is designed to treat patients with abdominal aortic aneurysms (AAA), a potentially life-threatening condition that occurs when the wall of the aorta weakens and bulges. The system consists of a flexible stent graft that is delivered through a catheter and expands to fit inside the damaged area of the aorta.

Report Analysis	Details
Historical data	2016 - 2021
Forecast Period	2022 - 2029
Market Size in 2022:	USD 1.79 Billion
Base year considered	2021
Forecast Period CAGR %:	7.38%
Market Size Expected in 2029:	USD 2.95 Billion
Tables, Charts & Figures:	175
Pages	300
Companies	Abbott Laboratories, B. Braun Melsungen AG, C.R. Bard, Inc., Cardinal Health, Inc., Cook Medical, CryoLife, Inc., Endologix, Inc., Japan Lifeline Co., Ltd., LeMaitre Vascular, Inc., MAQUET Holding B.V. & Co. KG (Getinge AB), Medtronic plc, Novatech SA, Terumo Corporation, Vascular Grafts Solutions Ltd., W. L. Gore & Associates, Inc. Others
Segments Covered	By Graft Material, By Product, By End user, By Application
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa